Researchers combined two forms of circular-dichroism spectroscopy with imaging to compare the amount of collagen in skin tissue sections with the organization, or handedness, of its larger molecular structure; one method used synchrotron vacuum-ultraviolet light and the other a quantum-cascade laser. [1]

The paper's July 19 account of an AI blood score in biobank data kept a predictive signal below an available clinical test; this method remains on the same side of that boundary, because naming a signal is not the same as delivering a validated service.

ScienceDaily says collagen's supramolecular organization deteriorated while collagen content and visible fiber coverage remained comparatively intact, allowing the laboratory method to reveal structural change before ordinary images showed fiber thinning or fragmentation; the measured distinction was between quantity and structural coherence within the same tissue. [1]

That result does not establish an early diagnosis for a patient, because the release supplies no sample denominator, donor population, clinical threshold, sensitivity, specificity, repeatability, prognosis or evidence that acting on the signal improves an outcome, and it reports no patient symptoms or treatment responses.

The promising object here is a way to study tissue organization, not a consumer scanner or a prediction about aging: the primary paper, tissue source, experimental conditions, blinding and cross-laboratory performance still need inspection before hidden structure becomes a useful medical measure, and no available device was reported.

-- KENJI NAKAMURA, Tokyo